药品短缺相关药物不良反应:法国国家药物警戒数据库回顾性研究
该研究基于法国国家药物警戒数据库1985年至2019年底记录的药品短缺相关病例,共纳入462例。病例数从2004年至2019年显著增加,主要涉及神经系统、心血管系统和抗感染药物。半数病例被判定为严重,5.8%报告死亡和/或危及生命的情况,11%存在用药错误,15.9%出现疾病恶化且多与替代药物疗效不足相关。
要点
- 药品短缺相关药物不良反应病例数自2004年至2019年显著增加。
- 涉及药物以神经系统、心血管系统和抗感染药为主。
- 半数病例为严重不良反应,5.8%报告死亡和/或危及生命。
核心结论
- 药品短缺在药物不良反应、用药错误和疗效不足方面具有明确的临床影响。
- 研究结果强调需要全球卫生政策规划以减少药品短缺发生,并加强向患者和医务人员提供相关信息以降低风险。
研究设计与样本
- 研究为基于法国国家药物警戒数据库的回顾性研究。
- 提取1985年至2019年底数据库中所有涉及药品短缺的报告病例,经筛选后纳入462例。
主要发现
- 病例数从2004年至2019年显著增加。
- 涉及药物主要为神经系统(22.1%,95%CI 17.5-27.0%)、心血管系统(16.4%,95%CI 11.9-21.4%)和抗感染药(14.3%,95%CI 9.7-19.2%)ATC类别。
- 报告的药物不良反应主要属于神经系统(21%,95%CI 18-24%)、皮肤和皮下组织(14%,95%CI 11-17%)、全身性(13%,95%CI 10-17%)和胃肠道(8%,95%CI 5-11%) disorders。
- 15.9%的病例出现疾病恶化,主要与替代药物疗效不足相关;半数病例被判定为严重;79.4%的病例转归良好;5.8%的病例报告死亡和/或危及生命的情况。
- 51例(11%)存在用药错误,多发生于给药环节且涉及人为因素。
临床怎么用
- 临床应关注药品短缺期间替代药物的疗效不足风险及疾病恶化可能。
- 在药品短缺背景下需加强给药环节的用药错误防范,关注人为因素。
- 应向患者和医务人员强化药品短缺相关信息沟通以降低风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Drug shortages are a growing global health issue. The aim of the study was to evaluate the consequences of drug shortages on patient safety based on data recorded in the French National Pharmacovigilance Database. METHODS: All cases involving drug shortages reported from 1985 to the end of 2019 were extracted from the database. RESULTS: Following the selection process, 462 cases were included. The number of cases increased significantly from 2004 to 2019. Cases mainly involved drugs from the nervous system (22.1%, 95% confidence interval [CI] 17.5-27.0%), the cardiovascular system (16.4%, 95% CI 11.9-21.4%) and anti-infectives for systemic use (14.3%, 95% CI 9.7-19.2%) ATC classes. Most of the cases reported an adverse drug reaction (ADR) belonging to the SOC nervous system (21%, 95% CI 18-24%), skin and subcutaneous (14%, 95% CI 11-17%), general (13%, 95% CI 10-17%) and gastrointestinal (8%, 95% CI 5-11%) disorders. Disease worsening was observed in 15.9% of the cases, mostly related to a lack of efficacy of the replacement drug. Half of the cases were considered as serious. Evolution was favourable in 79.4% of the cases. Death and/or life-threatening situations were reported in 5.8% of the cases. Medication errors (MEs) were identified in 51 cases (11%), mostly occurring at the administration step and involving a human factor. CONCLUSION: This study emphasizes the clinical impact of drug shortage in terms of ADRs, ME and inefficiency. These observations underline the importance of a global health policy programme to limit the occurrence of drug shortages and to reinforce the information provided to patients and health care professionals in this context to limit risk.
引用
- Bourneau-Martin D, Babin M, Grandvuillemin A, et al. Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database. Br J Clin Pharmacol. 2022. PMID: 36177609. doi:10.1111/bcp.15550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。